清细胞乳头性脏细胞瘤:在世界卫生组织第五次分类重新命名后,对临床病理特征和分子景观的新见解
Wenhui Zhang1, Liang Zhang2, Zhu Wen1
1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Pathology, research and practice
|February 7, 2024
概括
清细胞乳头性脏细胞瘤 (CCPRCT) 呈现出明显的病理和有利的预后. 基因分析揭示了FLT和TTN基因的新变异,使其与其他细胞癌亚型区别开来.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 清细胞乳头性脏细胞瘤 (CCPRCT) 是世卫组织认可的一种独特的上皮质瘤.
- 它的特定生物机制和分子基础需要进一步阐明.
- 需要与流行细胞癌 (RCC) 亚型进行比较分析.
研究的目的:
- 综合评估CCPRCT的临床病理和分子特征.
- 为了比较CCPRCT与透明细胞RCC (ccRCC) 和乳头RCC (pRCC) 分子形状.
- 为了识别特定于CCPRCT的潜在遗传变异.
主要方法:
- 对12个CCPRCT病例的临床病理学分析.
- 整体外基因组测序 (WES) 用于CCPRCT的基因分析.
- 将CCPRCT遗传数据与TCGA的ccRCC (341例) 和pRCC (200例) 数据集进行比较.
主要成果:
- CCPRCT病例显示出固体囊的外观,中度的异型 (ISUP等级1-2),以及分散的CK7/CAIX阳性.
- 在33%的CCPRCT病例中,在TTN和FLT基因中发现了反复发生的突变.
- 与ccRCC和pRCC相比,CCPRCT的瘤突变负担 (TMB) 显着较低.
- 没有观察到转移,复发或与瘤有关的死亡病例.
结论:
- CCPRCT的特点是独特的临床和病理特征.
- 这项研究支持CCPRCT的良好预后.
- 在CCPRCT中发现了新的分子变异,包括FLT家族和TTN突变.
- 由于样本规模有限,需要进行更大规模的研究来验证这些发现.
相关概念视频
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K